Gland Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma Limited has submitted a confirmation certificate from its Registrar and Share Transfer Agent, M/s. MUFG Intime India Private Limited, for the quarter ended March 31, 2026. The certificate confirms that the RTA did not receive any requests for dematerialization or rematerialization of equity shares during this period. This is a routine regulatory filing required under SEBI regulations to ensure compliance with share registry procedures. The filing was made on April 13, 2026, to both BSE and NSE where the company's shares are listed.
This is a routine compliance filing with no direct impact on the company's financials or stock price. It simply confirms that no share dematerialization or rematerialization requests were processed during the quarter, indicating no major changes in shareholding structure through this channel.